10Y annualized return is
excellent
at 26.0% per year
PODD has met or exceeded earnings expectations in
most
recent quarters (9/10)
Strong Gross Profit Margin
Strong Return on Equity
High Price-to-Earnings Ratio
Elevated Price-to-Sales Ratio
Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.
Already have an account? Sign in
Overall, Insulet Corporation demonstrates strong business quality with impressive revenue growth, market leadership, and innovative products. Future prospects appear positive, particularly with the expansion into the type 2 diabetes market and international growth opportunities. However, competition and dependence on the U.S. market present challenges that could impact growth.
Analysis Date: February 20, 2025
Last Updated: May 29, 2025
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
Insulet Corporation makes a special device called the Omnipod, which helps people with diabetes manage their insulin levels. This device is small, sticky, and can be worn on the body for three days without needing to be replaced. It is wireless and comes with a handheld manager that helps users control their insulin delivery. The company sells these products in several countries, including the United States and Canada, to help make life easier for those who need insulin.
Streams of revenue
Geographic Distribution
Core Products
Business Type
Business to Consumer
Competitive Advantages
Discover all competitive advantages and strategic moats that protect PODD's market position.
View Premium AnalysisKey Business Risks
Get comprehensive insight into all key business risks that could impact PODD's performance.
Access Full Risk AnalysisTrailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
Access detailed profitability metrics with visual gauges and benchmarks
Access detailed analysis of profitability strengths and positive performance indicators
Upgrade to PremiumAccess detailed analysis of profitability weaknesses and areas of concern
Upgrade to PremiumFinancial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.
Access detailed financial health metrics with visual gauges and risk assessments
Access detailed analysis of financial health strengths and stability indicators
Upgrade to PremiumAccess detailed analysis of financial health weaknesses and risk factors
Upgrade to PremiumMeeting Expectations
Higher values indicate better execution and credibility
Recent Results
View complete earnings history and detailed performance analysis
Upgrade to PremiumEPS
Revenue
Insider trading data shows purchase and sale activities by company executives and board members.
Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.
Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights
